Unitedhealth Group Inc (NYSE:UNH) shares, rose in value, with the stock price down by -0.95% to the previous day’s close as strong demand from buyers drove the stock to $455.38.
Actively observing the price movement in the last trading, the stock closed the session at $459.74. The value of beta (5-year monthly) was 0.55 whereas the PE ratio was 19.09 over 12-month period. Referring to stock’s 52-week performance, its high was $554.70, and the low was $445.68. On the whole, UNH has fluctuated by -3.76% over the past month.
With the market capitalization of Unitedhealth Group Inc currently standing at about $419.83 billion, investors are eagerly awaiting this quarter’s results, scheduled for Apr 12, 2024 – Apr 16, 2024. The company’s Forward Dividend Ratio is 7.52, with its dividend yield at 1.65%. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be $6.73, which is expected to increase to $7.06 for fiscal year $27.75 and then to about $31.3 by fiscal year 2025. Data indicates that the EPS growth is expected to be 18.90% in 2025, while the next year’s EPS growth is forecast to be 12.80%.
Analysts have estimated the company’s revenue for the quarter at $92.37 billion, with a low estimate of $89.79 billion and a high estimate of $93.79 billion. According to the average forecast, sales growth in current quarter could jump up 2.90%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $372.33 billion, representing an increase of 7.90% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were 1 upward and no downward review(s) in last seven days. We see that UNH’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 1.42, with the price of UNH currently trading nearly -6.15% and -8.94% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 27.12, while the 7-day volatility ratio is showing 1.94% which for the 30-day chart, stands at 1.59%. Furthermore, Unitedhealth Group Inc (UNH)’s beta value is 0.57, and its average true range (ATR) is 9.92.
A comparison of Unitedhealth Group Inc (UNH) with its peers suggests the former has fared considerably weaker in the market. UNH showed an intraday change of -0.95% in last session, and over the past year, it shrunk by -7.85%%.
Data on historical trading for Unitedhealth Group Inc (NYSE:UNH) indicates that the trading volumes over the past 10 days have averaged 4.17 million and over the past 3 months, they’ve averaged 4.24 million. According to company’s latest data on outstanding shares, there are 924.00 million shares outstanding.
Nearly 0.18% of Unitedhealth Group Inc’s shares belong to company insiders and institutional investors own 90.47% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 7.29 million shares as on Mar 15, 2024, resulting in a short ratio of 1.67. According to the data, the short interest in Unitedhealth Group Inc (UNH) stood at 0.79% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 6.34 million. The stock has fallen by -13.50% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the UNH stock heading into the next quarter.
